Isomorphic Labs announces the appointment of Max Jaderberg as President of the company effective 1 January 2026, transitioning from his current role as Isomorphic Labs’ Chief AI Officer. Colin Murdoch will step down from his role as President following a successful tenure leading the company through its breakout phase.
Max Jaderberg was a founding member of the Isomorphic Labs team and has built the company’s approach to AI from the ground-up, spearheading the development of an AI drug design engine that enables scientists to probe new chemical space, explore previously intractable targets, and design new drug candidates with greater pace and precision.
Read more in the news release below.
